Literature DB >> 764937

The treatment of malaria.

A P Hall.   

Abstract

At least four doses of quinine followed by a single dose of mefloquine or by a single dose of sulfadoxine-pyrimethamine are two highly effective regimens for chloroquine-resistant falciparum malaria. Mefloquine alone is valuable in ambulant patients. Chloroquine-sensitive falciparum malaria can be treated with a course of chloroquine. Vivax and all other types of malaria should be treated with sequential chloroquine and primaquine. Quinine, by intravenous infusion, is the most effective drug for severe falciparum malaria. The optimum intravenous dose varies between 5 mg/kg and 10 mg/kg administered over four hours. Intravenous or oral quinine should be administered about every 12 hours and the total daily dose of quinine should rarely exceed 20 mg/kg. Intravenous fluid input should be controlled in falciparum malaria to prevent pulmonary oedema. Established renal failure is best treated by dialysis. The value of adrenocortical steroids for falciparum coma has not been established. Fresh blood transfusion may be helpful in small doses for severe anaemia and to replace clotting factors. Anticoagulants, such as heparin, should not be used in falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 764937      PMCID: PMC1638678          DOI: 10.1136/bmj.1.6005.323

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  67 in total

1.  Chemoprophylaxis of malaria for travelers.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

Review 2.  Drugs five years later: dextran 40.

Authors:  J L Data; A S Nies
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

3.  Recrudescent falciparum malaria in Vietnam.

Authors:  A P Hall
Journal:  Am J Trop Med Hyg       Date:  1973-05       Impact factor: 2.345

4.  Quinine-tetracycline and quinine-bactrim treatment of acute falciparum malaria in Thailand.

Authors:  E J Colwell; R L Hickman; S Kosakal
Journal:  Ann Trop Med Parasitol       Date:  1973-06

5.  Clinical testing of new antimalarial compounds.

Authors:  C J Canfield; R S Rozman
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

6.  Coombs'-positive hemolytic disease in malaria.

Authors:  M M Adner; L B Altstatt; M E Conrad
Journal:  Ann Intern Med       Date:  1968-01       Impact factor: 25.391

7.  Spontaneous splenic rupture in vivax malaria: case report.

Authors:  W A Howard; W A Krotoski; M S Slonim; P G Contacos
Journal:  Mil Med       Date:  1973-01       Impact factor: 1.437

8.  Letter: Intravascular coagulation and malaria.

Authors:  R Petchclai; S Prasongsom; W Benjapongs
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

9.  Letter: Adjuvant treatment of severe falciparum malaria, intravascular coagulation, and heparin.

Authors:  H A Reid
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

10.  Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria.

Authors:  T Srichaikul; P Puwasatien; J Karnjanajetanee; V A Bokisch; P Pawasatien
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

View more
  24 in total

1.  Reading for Pleasure: Short and good.

Authors:  J C Griffiths
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

2.  Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.

Authors:  S M Mansor; V Navaratnam; M Mohamad; S Hussein; A Kumar; A Jamaludin; W H Wernsdorfer
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  Quinine induced Escherichia coli DNA base-pair substitution mutation.

Authors:  E E Obaseiki-Ebor; E E Obasi
Journal:  Bull Environ Contam Toxicol       Date:  1987-03       Impact factor: 2.151

Review 4.  Tropical respiratory medicine. 4. Acute tropical infections and the lung.

Authors:  S Johnson; R Wilkinson; R N Davidson
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

5.  Current concepts in the treatment of malaria in children.

Authors:  B R Thapa; R K Marwaha
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

6.  Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.

Authors:  E Weidekamm; H Plozza-Nottebrock; I Forgo; U C Dubach
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  The six diseases of WHO. Malaria.

Authors:  H M Gilles
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

8.  Fatal falciparum malaria and the availability of parenteral antimalarial drugs in hospitals.

Authors:  K M De Cock
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

Review 9.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

10.  Haemostatic defect in non-immune patients with falciparum malaria: no evidence of diffuse intravascular coagulation.

Authors:  J Vreeken; T M Cremer-Goote
Journal:  Br Med J       Date:  1978-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.